Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 3,327.00
+7.40 (0.22%)
Nov 12, 2026, 3:29 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 415.66 billion as of November 12, 2026. It is the 3,956th most valuable company in the world and the 234th biggest in India. Its market cap has increased by 29.12% in one year.
Market Cap
415.66B
Enterprise Value
410.40B
Revenue
62.17B
Global Rank
Country Rank
#234 India
PE Ratio
32.93
ChartMarket Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 415.66B, an increase of 73,364.83%. That is a compound annual growth rate of 30.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 415.29B | 20.09% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 755.56B |
| Alkem Laboratories | 651.39B |
| Gland Pharma | 537.79B |
| Ipca Laboratories | 492.19B |
| Emcure Pharmaceuticals | 423.94B |
| Wockhardt | 329.86B |
| Piramal Pharma | 326.07B |
| Alembic Pharmaceuticals | 202.36B |